Filtered By:
Condition: Ischemic Stroke
Drug: Plavix
This page shows you your search results in order of date. This is page number 12.
Order by Relevance | Date
Total 1287 results found since Jan 2013.
Impact of platelet endothelial aggregation receptor 1 genotypes and DNA methylation on platelet reactivity in patients with recurrent ischemic stroke treated with clopidogrel
CONCLUSIONS: The PEAR1 rs12041331 genetic polymorphism and DNA methylation may be among the genetic factors affecting HPR. The correlation between PEAR1 and RIS needs to be studied further.PMID:37034521 | PMC:PMC10074304 | DOI:10.5114/aoms/159180
Source: Archives of Medical Science - April 10, 2023 Category: General Medicine Authors: Jiahui Yang Zhengjun Bao Guoyu Hu Xiaopeng Luo Zhen Zhao Source Type: research
Comparison of Prasugrel and Clopidogrel in Thrombotic Stroke Patients with Risk Factors for Ischemic Stroke Recurrence: An Integrated Analysis of PRASTRO-I, PRASTRO-II, and PRASTRO-III
Conclusions: This integrated analysis supports the findings of PRASTRO-III. Prasugrel is a promising treatment that results in a numerical reduction in the composite incidence of ischemic stroke, MI, and death from other vascular causes in patients with ischemic stroke who are at a high risk of stroke recurrence. No major safety issues were observed for prasugrel.Cerebrovasc Dis
Source: Cerebrovascular Diseases - April 3, 2023 Category: Neurology Source Type: research
